Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities

Completed · Not applicable

Conditions studied: Diabetes Mellitus

In brief

The investigators propose a randomized encouragement trial to encourage use of the existing mail order pharmacy services among diabetes patients with poor adherence to CVD risk factor medications in 3 health care systems: Kaiser Permanente Northern California, Harvard Pilgrim, and Kaiser Permanente Hawaii.

Key facts

Study ID

NCT02621476

Run by

Kaiser Permanente

People needed

63012

Starts

2017-02-01

Expected to finish

2022-05-30

Last updated by the study team

2023-08-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diabetes patients who are users of CVD risk factor medications (antihypertensive therapies, antihyperlipidemics therapies, and oral antihyperglycemic therapies),
• Diabetes patients considered to be poorly adherent to CVD risk factor medications within the prior 12 months
• Diabetes patients who have not used the mail order pharmacy to fill any prescribed medications at least once in the prior 12 months

You may not qualify if…

• Pregnancy or Dementia/Traumatic Brain Injury diagnosis in the prior 12 months
• Hospitalized, in Skilled Nursing Facility, Hospice, or Home Health at the time of randomization.

Where it is running

• Division of Research — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.